---
layout: post
title: "Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation"
date: 2026-02-05 19:08:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-04946
original_published: 2021-03-10 00:00:00 +0000
significance: 8.00
---

# Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 10, 2021 00:00 UTC
**Document Number:** 2021-04946

## Summary

In prior notices, the U.S. Trade Representative modified the action in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address the COVID-19 pandemic. To support efforts to combat COVID-19, on December 29, 2020, the U.S. Trade Representative announced the extension of certain product exclusions on medical-care and/or COVID response products and further modifications to remove Section 301 duties from additional medical-care and/or COVID response products. This notice announces the U.S. Trade Representative's determination to extend those exclusions.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/03/10/2021-04946/notice-of-product-exclusion-extensions-chinas-acts-policies-and-practices-related-to-technology)
- API: https://www.federalregister.gov/api/v1/documents/2021-04946

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
